Tislelizumab,Sorafenib
BeiGene,bayer,novartis
['tislelizumab', 'beigene', '$bgne']
$bgne beigene announces data presentations at esmo 2022 including late-breaking oral presentation for tislelizumab in first-line unresectable hepatocellular cancer #cancer
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft